［2023年5月18日］
香港紅十字會輸血服務中心今日表示，目前中心血庫存量已下降至極低水平，僅餘四日存量，當中以O型、A型及B型尤為短缺，中心現緊急呼籲市民前往捐血，以維持穩定血液供應，為病人提供適切的臨床輸血治療。
中心發言人指出，早前天氣不穩影響市民捐血意欲，加上正值住院服務高峰期，公立醫院服務等需求極為殷切，對血液需求不斷上升，每日血液收集量難以維持全港醫院所需。全港醫院每日都需要血液以治理不同傷患，各大醫院的急症室、緊急手術等手術，均需要用上大量血液；而地中海貧血症及血癌等病人的治療過程中，亦依賴足夠的血液支援。
凡年齡介乎16至65歲（符合特定條件人士可捐血至75歲），體重達41公斤或以上的健康人士均可加入捐血者的行列。中心誠邀市民致電各捐血站或透過手機應用程式「HK Blood」預約捐血，詳情請參閱香港紅十字會輸血服務中心網站。
The spokesperson for the Hong Kong Red Cross Blood Transfusion Service (BTS) today (May 18) urgently appeals to members of the public to donate blood as the inventories have been depleted to a very low level, with only four days of stock. The BTS urgently appeals to donors, especially Type O, Type A and Type B donors, to come forward and give blood to replenish blood inventories to facilitate clinical transfusions.
As blood collection continues to drop amid the unstable weather earlier, together with the increasing blood demand from public hospitals due to the service surge, daily blood collection remains unstable and has been unable to meet the daily target. Blood collection is crucial for emergency operations and organ transplants, as well as for meeting blood demand from thalassemia and blood cancer patients.
Members of the public aged between 16 and 65 (donation is possible up to the age of 75 if predetermined conditions are met), weighing 41 kilograms or above and in good health are eligible to give blood. The BTS reminds donors to make appointment by calling the BTS donor centres, booking online or via the "HK Blood" mobile apps. For details, please visit the website of the Hong Kong Red Cross Blood Transfusion Service.
⬇️登入網頁接收最新港聞⬇️
https://www.cvrhk.com
-------------------------------------------------
*訂閱、追蹤《全民新聞》YOUTUBE頻道:
https://www.youtube.com/c/全民新聞CVRHK
-------------------------------------------------
支持《全民新聞》，只需課「Like」、課「分享」！動動手指讚好、分享我哋嘅新聞 Post 同留言，就係對我哋最有效率嘅支持！全民一齊支持本地新聞媒體！
-------------------------------------------------
支持全民小店《維瓦》，等於支持全民！
*全民小店購物《維瓦völva》FB專頁:
https://www.facebook.com/volvahk
《維瓦》店舖地址：
旺角西洋菜南街銀城廣場地庫B31號舖
コメント